Back
BridgeBio Pharma Stock Price Chart
Sponsored
BBIO
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
BBIO
BridgeBio Pharma
Last Price:
$28.53
Seasonality Move:
-20.12%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.25 | Buy |
20-day SMA: | 27.5 | Buy |
50-day SMA: | 25.84 | Buy |
200-day SMA: | 26.62 | Buy |
8-day EMA: | 27.48 | Buy |
20-day EMA: | 27.11 | Buy |
50-day EMA: | 26.39 | Buy |
200-day EMA: | 26.67 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.5 | Buy |
Relative Strength Index (14 RSI): | 59.14 | Buy |
Chaikin Money Flow: | 838229 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.92 - 28.64) | Buy |
Bollinger Bands (100): | (24.04 - 27.72) | Buy |
BridgeBio Pharma Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 28.53 while BBIO 8-day simple moving average is 27.25, which is a Buy signal.
-
The stock price of BBIO is 28.53 while BridgeBio Pharma 20-day SMA is 27.50, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 25.84 while BBIO share price is 28.53, making it a Buy technically.
-
BBIO stock price is 28.53 and BridgeBio Pharma 200-day simple moving average is 26.62, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Buy
51
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a BuyThe current BridgeBio Pharma [BBIO] share price is $28.53. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
5.4B
Price in USD:
28.53
Share Volume:
939K
BridgeBio Pharma 52-Week Range
52-Week High:
44.32
52-Week Low:
21.62
Buy
51
BridgeBio Pharma (BBIO)
is a Buy
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 28.53 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is not overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 28.53 while BBIO 8-day exponential moving average is 27.48, which is a Buy signal.
-
The stock price of BBIO is 28.53 while BridgeBio Pharma 20-day EMA is 27.11, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 26.39 while BBIO share price is 28.53, making it a Buy technically.
-
BBIO stock price is 28.53 and BridgeBio Pharma 200-day simple moving average is 26.67, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $1.07 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 0.5, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 59.14, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (24.92 - 28.64), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (24.04 - 27.72), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.